Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 3/2019

26.04.2019 | Research Article

Perceived sensitivity to medicines: a study among chronic medicine users in Norway

verfasst von: Karin Svensberg, Hedvig Nordeng, Sahar Gaffari, Kate Faasse, Rob Horne, Angela Lupattelli

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Background Little is known about patients’ Perceived Sensitivity to Medicines (PSM), “the belief that one is especially sensitive to the actions and side effects of medicines”. Objective (i) To explore the extent of and factors associated with high Perceived Sensitivity to Medicines in a Norwegian population of chronic medicine users; (ii) to assess the psychometric characteristics of the tool to measure PSM. Setting Community pharmacies in the Oslo area, Norway. Method A cross-sectional, questionnaire-based study was conducted between October 2015 and January 2016. Patients filling prescriptions for chronic disorders were recruited. Main outcome measure Perceived sensitivity to medicines. Results The study population included 214 patients (response rate 36.7%). In total 20.1% of the patients reported low, 61.7% moderate and 18.2% high perceived sensitivity to medicines. Factors positively associated with high perceived sensitivity were female gender (Adjusted Odds Ratio (aOR) 5.33, 95% CI 1.52 to 18.72, p < 0.001) and having a non-native language (aOR 4.76, 95% CI 1.48 to 15.30, p < 0.001); lower educational level (aOR 0.43, 95% CI 0.17 to 1.07, p < 0.001) and using generic medicines (aOR 0.12, 95% CI 0.03 to 0.57, p < 0.001) were negatively associated with high perceived sensitivity to medicines. There was no association between the perceived sensitivity and the number of prescription medicines taken. The Norwegian version of the Perceived Sensitivity to Medicines tool demonstrated good psychometric characteristics. Conclusion Almost one out of five patients in this study reported high sensitivity to medicines. Female gender, having a non-native language, lower educational level and using generic medicines were important factors related to the perceived sensitivity. Health care providers should be aware of the impact negative expectations about medicines can have on health behaviors and treatment outcomes, and seek to elicit and address patients’ beliefs about their personal sensitivity to medicines.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Nestoriuc Y, Orav EJ, Liang MH, Horne R, Barsky AJ. Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines. Arthritis Care Res (Hoboken). 2010;62(6):791–9.CrossRef Nestoriuc Y, Orav EJ, Liang MH, Horne R, Barsky AJ. Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines. Arthritis Care Res (Hoboken). 2010;62(6):791–9.CrossRef
2.
Zurück zum Zitat Horne R, Faasse K, Cooper V, Diefenbach MA, Leventhal H, Leventhal E, et al. The perceived sensitivity to medicines (PSM) scale: an evaluation of validity and reliability. Br J Health Psychol. 2013;18(1):18–30.CrossRefPubMed Horne R, Faasse K, Cooper V, Diefenbach MA, Leventhal H, Leventhal E, et al. The perceived sensitivity to medicines (PSM) scale: an evaluation of validity and reliability. Br J Health Psychol. 2013;18(1):18–30.CrossRefPubMed
3.
Zurück zum Zitat Espay AJ, Norris MM, Eliassen JC, Dwivedi A, Smith MS, Banks C, et al. Placebo effect of medication cost in Parkinson disease: a randomized double-blind study. Neurology. 2015;84(8):794–802.CrossRefPubMedPubMedCentral Espay AJ, Norris MM, Eliassen JC, Dwivedi A, Smith MS, Banks C, et al. Placebo effect of medication cost in Parkinson disease: a randomized double-blind study. Neurology. 2015;84(8):794–802.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Andersson Sundell K, Jonsson AK. Beliefs about medicines are strongly associated with medicine-use patterns among the general population. Int J Clin Pract. 2016;70(3):277–85.CrossRefPubMed Andersson Sundell K, Jonsson AK. Beliefs about medicines are strongly associated with medicine-use patterns among the general population. Int J Clin Pract. 2016;70(3):277–85.CrossRefPubMed
5.
Zurück zum Zitat Faasse K, Grey A, Horne R, Petrie KJ. High perceived sensitivity to medicines is associated with higher medical care utilisation, increased symptom reporting and greater information-seeking about medication. Pharmacoepidemiol Drug Saf. 2015;24(6):592–9.CrossRefPubMed Faasse K, Grey A, Horne R, Petrie KJ. High perceived sensitivity to medicines is associated with higher medical care utilisation, increased symptom reporting and greater information-seeking about medication. Pharmacoepidemiol Drug Saf. 2015;24(6):592–9.CrossRefPubMed
6.
Zurück zum Zitat Faasse K, Petrie KJ. The nocebo effect: patient expectations and medication side effects. Postgrad Med J. 2013;89(1055):540–6.CrossRefPubMed Faasse K, Petrie KJ. The nocebo effect: patient expectations and medication side effects. Postgrad Med J. 2013;89(1055):540–6.CrossRefPubMed
7.
Zurück zum Zitat Stewart-Williams S, Podd J. The placebo effect: dissolving the expectancy versus conditioning debate. Psychol Bull. 2004;130(2):324–40.CrossRefPubMed Stewart-Williams S, Podd J. The placebo effect: dissolving the expectancy versus conditioning debate. Psychol Bull. 2004;130(2):324–40.CrossRefPubMed
8.
Zurück zum Zitat Colagiuri B, Zachariae R. Patient expectancy and post-chemotherapy nausea: a meta-analysis. Ann Behav Med. 2010;40(1):3–14.CrossRefPubMed Colagiuri B, Zachariae R. Patient expectancy and post-chemotherapy nausea: a meta-analysis. Ann Behav Med. 2010;40(1):3–14.CrossRefPubMed
9.
Zurück zum Zitat Nestoriuc Y, von Blanckenburg P, Schuricht F, Barsky AJ, Hadji P, Albert US, et al. Is it best to expect the worst? Influence of patients’ side-effect expectations on endocrine treatment outcome in a 2-year prospective clinical cohort study. Ann Oncol. 2016;27(10):1909–15.CrossRefPubMed Nestoriuc Y, von Blanckenburg P, Schuricht F, Barsky AJ, Hadji P, Albert US, et al. Is it best to expect the worst? Influence of patients’ side-effect expectations on endocrine treatment outcome in a 2-year prospective clinical cohort study. Ann Oncol. 2016;27(10):1909–15.CrossRefPubMed
10.
Zurück zum Zitat Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1–24.CrossRef Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1–24.CrossRef
11.
Zurück zum Zitat Wei L, Champman S, Li X, Li X, Li S, Chen R, et al. Beliefs about medicines and non-adherence in patients with stroke, diabetes mellitus and rheumatoid arthritis: a cross-sectional study in China. BMJ Open. 2017;7(10):e017293.CrossRefPubMedPubMedCentral Wei L, Champman S, Li X, Li X, Li S, Chen R, et al. Beliefs about medicines and non-adherence in patients with stroke, diabetes mellitus and rheumatoid arthritis: a cross-sectional study in China. BMJ Open. 2017;7(10):e017293.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Jonsdottir H, Friis S, Horne R, Pettersen KI, Reikvam A, Andreassen OA. Beliefs about medications: measurement and relationship to adherence in patients with severe mental disorders. Acta Psychiatr Scand. 2009;119(1):78–84.CrossRefPubMed Jonsdottir H, Friis S, Horne R, Pettersen KI, Reikvam A, Andreassen OA. Beliefs about medications: measurement and relationship to adherence in patients with severe mental disorders. Acta Psychiatr Scand. 2009;119(1):78–84.CrossRefPubMed
15.
Zurück zum Zitat Tan K, Petrie KJ, Faasse K, Bolland MJ, Grey A. Unhelpful information about adverse drug reactions. BMJ. 2014;349:g5019.CrossRefPubMed Tan K, Petrie KJ, Faasse K, Bolland MJ, Grey A. Unhelpful information about adverse drug reactions. BMJ. 2014;349:g5019.CrossRefPubMed
16.
Zurück zum Zitat Kirkwood BR, Sterne JAC. Essential medical statistics. 2nd ed. Malden: Blackwell; 2003. Kirkwood BR, Sterne JAC. Essential medical statistics. 2nd ed. Malden: Blackwell; 2003.
17.
Zurück zum Zitat Hosmer DW, Lemeshow S, Sturdivant RX. Applied logistic regression. 3rd ed. Hoboken: Wiley; 2013.CrossRef Hosmer DW, Lemeshow S, Sturdivant RX. Applied logistic regression. 3rd ed. Hoboken: Wiley; 2013.CrossRef
18.
Zurück zum Zitat Chapman SCE, Horne R, Chater A, Hukins D, Smithson WH. Patients’ perspectives on antiepileptic medication: relationships between beliefs about medicines and adherence among patients with epilepsy in UK primary care. Epilepsy Behav. 2014;31:312–20.CrossRefPubMed Chapman SCE, Horne R, Chater A, Hukins D, Smithson WH. Patients’ perspectives on antiepileptic medication: relationships between beliefs about medicines and adherence among patients with epilepsy in UK primary care. Epilepsy Behav. 2014;31:312–20.CrossRefPubMed
19.
Zurück zum Zitat Laferton JA, Kube T, Salzmann S, Auer CJ, Shedden-Mora MC. Patients’ expectations regarding medical treatment: a critical review of concepts and their assessment. Front Psychol. 2017;8:233.CrossRefPubMedPubMedCentral Laferton JA, Kube T, Salzmann S, Auer CJ, Shedden-Mora MC. Patients’ expectations regarding medical treatment: a critical review of concepts and their assessment. Front Psychol. 2017;8:233.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Gupta A, Thompson D, Whitehouse A, Collier T, Dahlof B, Poulter N, et al. Adverse events associated with unblinded, but not with blinded, statin therapy in the anglo-scandinavian cardiac outcomes trial—lipid-lowering arm (ASCOT–LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase. Lancet. 2017;389(10088):2473–81.CrossRefPubMed Gupta A, Thompson D, Whitehouse A, Collier T, Dahlof B, Poulter N, et al. Adverse events associated with unblinded, but not with blinded, statin therapy in the anglo-scandinavian cardiac outcomes trial—lipid-lowering arm (ASCOT–LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase. Lancet. 2017;389(10088):2473–81.CrossRefPubMed
21.
Zurück zum Zitat Preston RA, Materson BJ, Reda DJ, Williams DW. Placebo-associated blood pressure response and adverse effects in the treatment of hypertension: observations from a department of veterans affairs cooperative study. Arch Intern Med. 2000;160(10):1449–54.CrossRefPubMed Preston RA, Materson BJ, Reda DJ, Williams DW. Placebo-associated blood pressure response and adverse effects in the treatment of hypertension: observations from a department of veterans affairs cooperative study. Arch Intern Med. 2000;160(10):1449–54.CrossRefPubMed
22.
Zurück zum Zitat Heller MK, Chapman SCE, Horne R. No blank slates: pre-existing schemas about pharmaceuticals predict memory for side effects. Psychol Health. 2017;32(4):402–21.CrossRefPubMed Heller MK, Chapman SCE, Horne R. No blank slates: pre-existing schemas about pharmaceuticals predict memory for side effects. Psychol Health. 2017;32(4):402–21.CrossRefPubMed
23.
Zurück zum Zitat Horne R. Treatment perceptions and self-regulation. In: Leventhal H, Cameron LD, editors. The self-regulation of health and illness behaviour. London: Routledge; 2003. Horne R. Treatment perceptions and self-regulation. In: Leventhal H, Cameron LD, editors. The self-regulation of health and illness behaviour. London: Routledge; 2003.
24.
Zurück zum Zitat Kjoenniksen I, Lindbaek M, Granas AG. Patients’ attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci. 2006;28(5):284–9.CrossRefPubMed Kjoenniksen I, Lindbaek M, Granas AG. Patients’ attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci. 2006;28(5):284–9.CrossRefPubMed
25.
Zurück zum Zitat Chandler J, Owen M. Pharmaceuticals: the new brand arena. Int J Market Res. 2002;44(4):385–404. Chandler J, Owen M. Pharmaceuticals: the new brand arena. Int J Market Res. 2002;44(4):385–404.
26.
Zurück zum Zitat Dunne SS, Dunne CP. What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs. BMC Med. 2015;13:173.CrossRefPubMedPubMedCentral Dunne SS, Dunne CP. What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs. BMC Med. 2015;13:173.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Gandhi M, Aweeka F, Greenblatt RM, Blaschke TF. Sex differences in pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol Toxicol. 2004;44:499–523.CrossRefPubMed Gandhi M, Aweeka F, Greenblatt RM, Blaschke TF. Sex differences in pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol Toxicol. 2004;44:499–523.CrossRefPubMed
28.
Zurück zum Zitat Schwartz JB. The current state of knowledge on age, sex, and their interactions on clinical pharmacology. Clin Pharmacol Ther. 2007;82(1):87–96.CrossRef Schwartz JB. The current state of knowledge on age, sex, and their interactions on clinical pharmacology. Clin Pharmacol Ther. 2007;82(1):87–96.CrossRef
29.
Zurück zum Zitat Petrie KJ, Faasse K, Crichton F, Grey A. How common are symptoms? Evidence from a New Zealand national telephone survey. BMJ Open. 2014;4(6):e005374.CrossRefPubMedPubMedCentral Petrie KJ, Faasse K, Crichton F, Grey A. How common are symptoms? Evidence from a New Zealand national telephone survey. BMJ Open. 2014;4(6):e005374.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Nolke L, Mensing M, Kramer A, Hornberg C. Sociodemographic and health-(care-)related characteristics of online health information seekers: a cross-sectional German study. BMC Public Health. 2015;15:31.CrossRefPubMedPubMedCentral Nolke L, Mensing M, Kramer A, Hornberg C. Sociodemographic and health-(care-)related characteristics of online health information seekers: a cross-sectional German study. BMC Public Health. 2015;15:31.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Manierre MJ. Gaps in knowledge: tracking and explaining gender differences in health information seeking. Soc Sci Med. 2015;128:151–8.CrossRefPubMed Manierre MJ. Gaps in knowledge: tracking and explaining gender differences in health information seeking. Soc Sci Med. 2015;128:151–8.CrossRefPubMed
32.
Zurück zum Zitat Hallyburton A, Evarts LA. Gender and online health information seeking: a five survey meta-analysis. J Consum Health Internet. 2014;18(2):128–42.CrossRef Hallyburton A, Evarts LA. Gender and online health information seeking: a five survey meta-analysis. J Consum Health Internet. 2014;18(2):128–42.CrossRef
34.
Zurück zum Zitat Richardson A, Allen JA, Xiao H, Vallone D. Effects of race/ethnicity and socioeconomic status on health information-seeking, confidence, and trust. J Health Care Poor Underserved. 2012;23(4):1477–93.CrossRefPubMed Richardson A, Allen JA, Xiao H, Vallone D. Effects of race/ethnicity and socioeconomic status on health information-seeking, confidence, and trust. J Health Care Poor Underserved. 2012;23(4):1477–93.CrossRefPubMed
35.
Zurück zum Zitat Street LR, Gordon SH, Ward MM, Krupat LE, Kravitz LR. Patient participation in medical consultations: why some patients are more involved than others. Med Care. 2005;43(10):960–9.CrossRefPubMed Street LR, Gordon SH, Ward MM, Krupat LE, Kravitz LR. Patient participation in medical consultations: why some patients are more involved than others. Med Care. 2005;43(10):960–9.CrossRefPubMed
36.
Zurück zum Zitat Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007;45(2–3):107–14.CrossRefPubMed Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007;45(2–3):107–14.CrossRefPubMed
Metadaten
Titel
Perceived sensitivity to medicines: a study among chronic medicine users in Norway
verfasst von
Karin Svensberg
Hedvig Nordeng
Sahar Gaffari
Kate Faasse
Rob Horne
Angela Lupattelli
Publikationsdatum
26.04.2019
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 3/2019
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-019-00826-2

Weitere Artikel der Ausgabe 3/2019

International Journal of Clinical Pharmacy 3/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.